Table 2: Clinical data prior to PAE using Bletilla striata particles and each to follow-up evaluation.
Variable | Before (n = 72) | After (month) | F | P | |||
1 (n = 68) | 3 (n = 68) | 6 (n = 68) | 12 (n = 68) | ||||
IPSS (point) | 25.86 ± 3.53 | 21.15 ± 3.32 | 16.23 ± 3.80 | 12.03 ± 1.77 | 6.52 ± 1.51 | 113.42 | 0.000 |
QOL score | 4.56 ± 0.61 | 3.73 ± 0.53 | 2.81 ± 0.45 | 2.45 ± 0.39 | 1.26 ± 0.43 | 95.13 | 0.001 |
IIEF (point) | 13.48 ± 2.71 | 13.53 ± 2.63 | 13.91 ± 2.71 | 14.00 ± 2.67 | 13.65 ± 2.17 | 8.79 | 0.062 |
Qmax (ml/s) | 9.83 ± 2.14 | 13.26 ± 1.95 | 17.01 ± 2.32 | 17.52 ± 2.13 | 18.15 ± 2.33 | 112.18 | 0.000 |
PV (ml) | 82.61 ± 23.71 | 73.51 ± 12.58 | 53.58 ± 9.11 | 43.64 ± 7.80 | 32.78 ± 3.54 | 106.48 | 0.000 |
PRV (ml) | 131.52 ± 19.13 | 43.25 ± 7.68 | 30.63 ± 4.11 | 13.25 ± 2.93 | 10.89 ± 2.34 | 112.41 | 0.000 |
IPSS: International prostate symptom score; QOL: Quality of life; IIEF: International index of erectile function; Qmax: Peak urinary flow rate; PV: Prostate volume; PRV: Postvoid residual urine.